COVID-19 Anti-inflammatory Agents and Immunomodulators
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators

Released: April 07, 2022

Expiration: April 06, 2023

Vikramjit Mukherjee
Vikramjit Mukherjee, MD

Activity

Progress
1
Course Completed

Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.

In this episode, Vikramjit Mukherjee, MD, discusses the role and timing of these treatment options, including:

  • High-titer convalescent plasma
  • Corticosteroids
  • Interleukin-6 inhibitors (eg, tocilizumab)
  • Janus kinase inhibitors (eg, baricitinib)